This proposal deals with roles for arachidonic acid epoxygenases in regulating functions of epidermal keratinocytes. The cytochrome P450 CYP2B19 generates 14,15- and 11,12-epoxyeicosatrienoic (EET) acids from arachidonate. CYP2B19-expressing granular keratinocytes comprise the outermost, viable, cell layer of the epidermis, where the epidermal, water permeability barrier forms. Functions of these cells largely determine our ability to respond to, and recover from, hostile environments and injury. In the previous grant, we showed that 14,15-EET promotes keratinocyte comification, by mechanisms involving transglutaminase activation. Transglutaminase activities are essential for the transition of granular cells to squames (anucleated, comified cells) and for a competent epidermal barrier. We hypothesize that EETs are involved in controlling functions of terminally differentiated skin keratinocytes in vivo, that this regulation ultimately specifies epidermal barrier properties and, as consequence, ability to respond to and recover from harmful environmental stress and injury. This proposal investigates mechanisms how EETs exert their biological effects on keratinocytes in vitro and the effects of EETs on epidermal barrier function in vivo.
Aim 1 would prove whether P450-dependent metabolic activation or peroxisome proliferator-activated receptor (PPAR)a are involved in mediating 14,15-EET effects on keratinocytes cornification.
Aim 2 would prove whether CYP2B19 metabolites regulate transepidermal water loss or ceramide content, during repair of the barrier after tape stripping mouse skin. Finally, Aim 3 would prove the fundamental role of P450 epoxygenases in the epidermis by generating Cyp2b19 null mice and studying effects of loss of function on (a) ability of epidermal keratinocytes to differentiate and (b) competency of epidermal barrier functions in intact animals. Stratified squamous epithelia like the epidermis directly interface and function as a barrier to the environment; as such they are primary sites of disease and cancers. We propose to study how endogenously formed lipid mediators (EETs) regulate organ function. These studies are important to human health since defects in the epidermal barrier increase susceptibility to toxicities, physical injuries, infections, and even death by water loss. ? ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR045603-06
Application #
7039158
Study Section
Alcohol and Toxicology Subcommittee 4 (ALTX)
Program Officer
Baker, Carl
Project Start
2000-08-08
Project End
2008-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
6
Fiscal Year
2006
Total Cost
$267,786
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Bell, Jordan C; Strobel, Henry W (2012) Regulation of cytochrome P450 4F11 by nuclear transcription factor-?B. Drug Metab Dispos 40:205-11
Wang, Ying; Bell, Jordan C; Keeney, Diane S et al. (2010) Gene regulation of CYP4F11 in human keratinocyte HaCaT cells. Drug Metab Dispos 38:100-7
Du, Liping; Yin, Huiyong; Morrow, Jason D et al. (2009) 20-Hydroxylation is the CYP-dependent and retinoid-inducible leukotriene B4 inactivation pathway in human and mouse skin cells. Arch Biochem Biophys 484:80-6
Kalsotra, Auinash; Du, Liping; Wang, Ying et al. (2008) Inflammation resolved by retinoid X receptor-mediated inactivation of leukotriene signaling pathways. FASEB J 22:538-47
Du, Liping; Yermalitsky, Valery; Hachey, David L et al. (2006) A biosynthetic pathway generating 12-hydroxy-5,8,14-eicosatrienoic acid from arachidonic acid is active in mouse skin microsomes. J Pharmacol Exp Ther 316:371-9
Du, Liping; Neis, Mark M; Ladd, Patricia A et al. (2006) Differentiation-specific factors modulate epidermal CYP1-4 gene expression in human skin in response to retinoic acid and classic aryl hydrocarbon receptor ligands. J Pharmacol Exp Ther 319:1162-71
Du, Liping; Neis, Mark M; Ladd, Patricia A et al. (2006) Effects of the differentiated keratinocyte phenotype on expression levels of CYP1-4 family genes in human skin cells. Toxicol Appl Pharmacol 213:135-44
Du, Liping; Yermalitsky, Valery; Ladd, Patricia A et al. (2005) Evidence that cytochrome P450 CYP2B19 is the major source of epoxyeicosatrienoic acids in mouse skin. Arch Biochem Biophys 435:125-33
Wang, Haoyi; Donley, Kyle M; Keeney, Diane S et al. (2003) Organization and evolution of the Cyp2 gene cluster on mouse chromosome 7, and comparison with the syntenic human cluster. Environ Health Perspect 111:1835-42
Ladd, Patricia A; Du, Liping; Capdevila, Jorge H et al. (2003) Epoxyeicosatrienoic acids activate transglutaminases in situ and induce cornification of epidermal keratinocytes. J Biol Chem 278:35184-92

Showing the most recent 10 out of 11 publications